Methylphenidate Hydrochloride
Payments companies reported to CMS as associated with Methylphenidate Hydrochloride. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Methylphenidate Hydrochloride, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Methylphenidate Hydrochloride
These are the largest totals companies reported as associated with Methylphenidate Hydrochloride. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Joan Mahoney | Smithtown, NY | Psychiatric/Mental Health (Nurse Practitioner) | $82.55 |
| Faisal Rafiq | Amityville, NY | Psychiatry | $82.55 |
| Diane Matsumoto | Phoenix, AZ | Pediatrics | $81.53 |
| Brandy Tomlinson | Lebanon, TN | Family | $77.92 |
| Samuel Paris | Franklin, TN | Primary Care | $77.10 |
| Noelle Miller | Phoenix, AZ | Pediatrics | $75.05 |
| Bryon Evans | Atlanta, GA | Psychiatry | $73.79 |
| Robert Chudnow | Plano, TX | Neurology With Special Qualifications In Child Neurology | $73.65 |
| Brandy Martinez | Costa Mesa, CA | Medical | $73.45 |
| Yvette Elpidio | Orange, CA | Psychiatric/Mental Health (Nurse Practitioner) | $73.45 |
Prescribed Methylphenidate Hydrochloride?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.